| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 45.16× | 45.16× | 47.30× | 55.51× | 58.82× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.22× | 1.22× | 1.30× | 1.26× | 1.33× | ||
| 0.98× | 0.98× | 0.82× | 1.08× | 1.09× | ||
| 0.70× | 0.70× | 0.61× | 0.77× | 0.72× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 58.82 | 55.51 | 47.30 | 45.16 | 45.16 | |
| Asset Turnover | 1.33 | 1.26 | 1.30 | 1.22 | 1.22 | |
| Cash Conversion (CFO/Net Income) | 1.09 | 1.08 | 0.82 | 0.98 | 0.98 | |
| CFO/EBITDA | 0.72 | 0.77 | 0.61 | 0.70 | 0.70 |